U.S. Business Inventories Show Modest Rise, Below Forecast
The United States Department of Commerce reported a slight increase in business inventories, a key measure of the change in the worth of unsold goods held by manufacturers,...
The United States Department of Commerce reported a slight increase in business inventories, a key measure of the change in the worth of unsold goods held by manufacturers,...
(Bloomberg) -- The great run in European government bonds is coming to an end, according to a portfolio manager at J.P. Morgan Asset Management, who is now betting Australia will be the next market to outperform.Most Read from BloombergHow California Sees the World, and ItselfHong Kong's Expat Party Hub Reshaped by Chinese InfluxLondon’s Tube Fares Are Set to Rise by 4.6% Next YearKim Crawford said there is little room for further gains in Europe compared to peers given swap markets are fairly p
CRWD has been on an uptrend since early August
The cost of borrowing money will likely continue to drop, underpinning riskier assets like bitcoin, says Scott Garliss.
TORONTO (Reuters) - Canada's annual inflation rate unexpectedly slowed by a tick to 1.9% in November, driven by a broad-based slowdown in prices, and the consumer price index was...
TORONTO (Reuters) - Canada's annual inflation rate unexpectedly slowed by a tick to 1.9% in November, driven by a broad-based slowdown in prices, and the consumer price index was...
US industrial production saw a slight decline according to recent data, marking a continued slowdown in the manufacturing sector. The actual figure came in at a decrease of 0.1%,...
US benchmark equity indexes were lower intraday as the Federal Reserve kicked off its two-day moneta
‘ResiClub’ compiled both public and private mortgage rate forecasts for the end of 2025. Here’s where they predict rates will go.
Cantor initiated coverage on Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company with five commercialized products. The company also collaborates with pharmaceutical companies to bring new molecules to market using its technologies, like PharmFilm. Aquestive is advancing a late-stage proprietary product candidate for severe allergic reactions, including anaphylaxis, and an earlier-stage epinephrine prodrug topical gel for various dermatology conditions. Cantor highlights that th